Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1997
10/30/1997CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997CA2252509A1 Matrix metalloprotease
10/30/1997CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997CA2251934A1 Secreted proteins and polynucleotides encoding them
10/29/1997EP0803573A1 Polycistronic expression construct with cytokines for multivalent vaccines
10/29/1997EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997EP0802976A2 Stabilized external guide sequences
10/29/1997EP0802974A1 Neuron promoter and uses
10/29/1997EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997CN1163146A Cardio-sodium complementary DNA eucaryon expression plasmid component and its muscle introduction therapy
10/28/1997US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997US5681940 Sugar modified nucleosides and oligonucleotides
10/28/1997US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997US5681746 Genetic engineering
10/28/1997US5681744 Delivery and expression of heterologus genes using upstream enhancer regions of mammalian gene promoters
10/28/1997US5681735 Transcription control element for increasing gene expression in myoblasts
10/28/1997US5681701 Testing a drug by exposing a culture of the osteoblastic cells which express a temperature sensitive mutant of simian virus large t antigen to the drug and monitoring the effect
10/28/1997US5681562 Lymphokine gene therapy of cancer
10/28/1997US5681559 Method for producing a highly enriched population of hematopoietic stem cells
10/23/1997WO1997039135A1 Enhanced expression of transgenes
10/23/1997WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997WO1997039126A1 Novel rantes homolog from prostate
10/23/1997WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997039022A1 Novel compounds
10/23/1997WO1997039019A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/1997WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997WO1997038729A1 In vivo gene transfer methods for wound healing
10/23/1997WO1997038723A1 Targeted viral vectors
10/23/1997WO1997038722A1 Novel compounds
10/23/1997WO1997038721A1 Novel compounds
10/23/1997WO1997038720A1 Novel compounds
10/23/1997WO1997038719A1 Novel compounds
10/23/1997WO1997038718A1 Novel compounds
10/23/1997WO1997038717A1 Novel compounds
10/23/1997WO1997038716A1 Novel compounds
10/23/1997WO1997038715A1 Novel compounds
10/23/1997WO1997038714A1 Novel compounds
10/23/1997WO1997035005A3 Cftr gene regulator
10/23/1997WO1997032019A3 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
10/23/1997WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997WO1997024446A3 Gene delivery vehicle-targeting ligands
10/23/1997DE19617837A1 Anticancer vaccine containing human dendritic cells
10/23/1997DE19615803A1 CELO-Virus CELO virus
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997CA2251738A1 Targeted viral vectors
10/23/1997CA2251543A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/1997CA2251115A1 Novel rantes homolog from prostate
10/23/1997CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/22/1997EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997EP0801575A1 Retroviral vectors for expression in embryonic cells
10/22/1997EP0557459B1 Bifunctional selectable fusion genes
10/22/1997CN1162978A Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
10/22/1997CN1162643A Preparation and usage of molecular chimera for curing cancer
10/22/1997CN1162642A Preparation of reagent for bisexual protein transfecting pharmaceutics
10/21/1997US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997US5679555 Method of using ribozyme analogs having rigid, non-nucleotidic molecular linkers
10/21/1997US5679554 Finderons and methods of their preparation and use
10/16/1997WO1997038137A1 Hereditary hemochromatosis gene
10/16/1997WO1997038119A1 Reagent and method for targeting retrovirus
10/16/1997WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997WO1997038109A1 Immunological rejection of transfected tumour cells
10/16/1997WO1997038100A1 Human cachexia associated protein
10/16/1997WO1997038091A1 METHODS FOR ENHANCING ANIMAL GROWTH AND CELL PROLIFERATION BY ELIMINATION OF FUNCTIONAL p27?Kip1¿
10/16/1997WO1997038087A2 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
10/16/1997WO1997038085A2 Genes amplified in cancer cells
10/16/1997WO1997038012A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997WO1997037998A2 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997WO1997037995A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997WO1997037966A1 Quaternary cytofectins
10/16/1997WO1997037684A1 Method for gene transfer to the central nervous system
10/16/1997WO1997037678A1 Drug for the treatment of tumours
10/16/1997WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997WO1997037542A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997CA2251078A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997CA2251072A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997CA2250868A1 Human cachexia associated protein
10/16/1997CA2250839A1 Drug for the treatment of tumours
10/16/1997CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997CA2250722A1 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997CA2250268A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997CA2249213A1 Extracellular/epidermal growth factor-like protein
10/15/1997EP0800830A2 Method of in vivo delivery of functioning foreign genes
10/15/1997EP0800581A1 POLYMERASE $g(d) MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS